BioCentury | Apr 9, 2020
Tools & Techniques

NCI takes lead on serological test validation as cancer center joins COVID-19 fight

Deploying its HPV serology testing lab to validate COVID-19 assays is one of three ways NIH’s National Cancer Institute is retooling cancer research activities to take on the pandemic. In a virtual advisory committee meeting...
BC Innovations | Nov 12, 2015
Translation in Brief

First world problems

As the microbiome sheds its status as fringe science and moves to the mainstream, leading researchers are grappling with how to solve problems and create common standards that will set the field on the right...
BC Extra | Oct 29, 2015
Politics & Policy

Scientists call for microbiome consortium

An interdisciplinary group of U.S. scientists proposed the creation of the Unified Microbiome Initiative, a consortium to coordinate funding from federal institutions, private foundations and industry to advance understanding and applications of Earth's microbial ecosystems....
BioCentury | Sep 5, 2005
Strategy

Back to School: Innovation & economics

Entering the second half of the decade, and a five full years after the genomics bubble popped, the biopharmaceutical industry and its financiers are beset with doubts about business models, the ability to raise money,...
BC Week In Review | May 2, 2005
Company News

PharmaFrontiers scientific advisory board update

PharmaFrontiers Corp. (PFTR), The Woodlands, Texas   Business: Autoimmune, Gene/Cell therapy   Appointed: Eliezer Huberman, director of biological and biotechnological research at Argonne National Laboratory, as chairman  ...
BC Week In Review | Nov 12, 2001
Company News

Paradigm scientific advisory board update

Paradigm Genetics Inc. (PDGM), Research Triangle Park, N.C.   Business: Functional genomics, Agbio/Veterinary/Environmental, Nutraceuticals   Appointed: Ralph Bradshaw, professor of physiology and biophysics and of anatomy and neurobiology at the University of California, Irvine; John...
BioCentury | Feb 26, 2001
Strategy

Applying muscle to microarrays

Applying muscle to microarrays Company Existing Laboratory Products Microarray technology Market focus Partnerships/Technology licenses Agilent Instrumentation, software, liquid chromatography, mass spectrometry Inkjet-based Custom and prefabricated arrays and analysis software Oxford Gene Technology: license to microarray...
BioCentury | Feb 26, 2001
Strategy

Putting chips down

The race of new players into the microarray field reflects perceptions that the true market potential is yet untapped - indeed, that existing manufacturers have yet to fulfill customer needs - coupled to the belief that barriers...
BC Week In Review | Aug 16, 1999
Company News

Genencor, MicroGenomics Inc., Argonne National Laboratory, Eastman Chemical Co., Electrosynthesis Co. Inc. other research news

The partners said they have improved their continuous biocatalytic operating system, which uses metabolic pathway engineering (families of enzymes capable of multiple reactions) to produce chemicals from raw materials (see BioCentury, Aug. 24, 1998). The...
BC Week In Review | Aug 24, 1998
Company News

Genencor, MicroGenomics Inc., Argonne National Laboratory, Eastman Chemical Co., Electrosynthesis Co. Inc. other research news

The partners said they have synthesized ascorbic acid (vitamin C) using a biocatalytic fermentation system that combines several enzymatic steps within a single production organism and uses glucose as the main bulk raw material. They...
Items per page:
1 - 10 of 13
BioCentury | Apr 9, 2020
Tools & Techniques

NCI takes lead on serological test validation as cancer center joins COVID-19 fight

Deploying its HPV serology testing lab to validate COVID-19 assays is one of three ways NIH’s National Cancer Institute is retooling cancer research activities to take on the pandemic. In a virtual advisory committee meeting...
BC Innovations | Nov 12, 2015
Translation in Brief

First world problems

As the microbiome sheds its status as fringe science and moves to the mainstream, leading researchers are grappling with how to solve problems and create common standards that will set the field on the right...
BC Extra | Oct 29, 2015
Politics & Policy

Scientists call for microbiome consortium

An interdisciplinary group of U.S. scientists proposed the creation of the Unified Microbiome Initiative, a consortium to coordinate funding from federal institutions, private foundations and industry to advance understanding and applications of Earth's microbial ecosystems....
BioCentury | Sep 5, 2005
Strategy

Back to School: Innovation & economics

Entering the second half of the decade, and a five full years after the genomics bubble popped, the biopharmaceutical industry and its financiers are beset with doubts about business models, the ability to raise money,...
BC Week In Review | May 2, 2005
Company News

PharmaFrontiers scientific advisory board update

PharmaFrontiers Corp. (PFTR), The Woodlands, Texas   Business: Autoimmune, Gene/Cell therapy   Appointed: Eliezer Huberman, director of biological and biotechnological research at Argonne National Laboratory, as chairman  ...
BC Week In Review | Nov 12, 2001
Company News

Paradigm scientific advisory board update

Paradigm Genetics Inc. (PDGM), Research Triangle Park, N.C.   Business: Functional genomics, Agbio/Veterinary/Environmental, Nutraceuticals   Appointed: Ralph Bradshaw, professor of physiology and biophysics and of anatomy and neurobiology at the University of California, Irvine; John...
BioCentury | Feb 26, 2001
Strategy

Applying muscle to microarrays

Applying muscle to microarrays Company Existing Laboratory Products Microarray technology Market focus Partnerships/Technology licenses Agilent Instrumentation, software, liquid chromatography, mass spectrometry Inkjet-based Custom and prefabricated arrays and analysis software Oxford Gene Technology: license to microarray...
BioCentury | Feb 26, 2001
Strategy

Putting chips down

The race of new players into the microarray field reflects perceptions that the true market potential is yet untapped - indeed, that existing manufacturers have yet to fulfill customer needs - coupled to the belief that barriers...
BC Week In Review | Aug 16, 1999
Company News

Genencor, MicroGenomics Inc., Argonne National Laboratory, Eastman Chemical Co., Electrosynthesis Co. Inc. other research news

The partners said they have improved their continuous biocatalytic operating system, which uses metabolic pathway engineering (families of enzymes capable of multiple reactions) to produce chemicals from raw materials (see BioCentury, Aug. 24, 1998). The...
BC Week In Review | Aug 24, 1998
Company News

Genencor, MicroGenomics Inc., Argonne National Laboratory, Eastman Chemical Co., Electrosynthesis Co. Inc. other research news

The partners said they have synthesized ascorbic acid (vitamin C) using a biocatalytic fermentation system that combines several enzymatic steps within a single production organism and uses glucose as the main bulk raw material. They...
Items per page:
1 - 10 of 13